The METTL3 inhibitor STM2457 suppresses growth, invasiveness, and migration of intrahepatic cholangiocarcinoma (ICC) cells, induces apoptosis, and triggers cell cycle arrest, thereby significantly suppressing ICC progression and exhibiting superior anti-tumor effects (Ref. Here, METTL3 is linked to neoplasm.